TOVX
Price:
$0.3038
Market Cap:
$10.84M
Theriva Biologics Inc. is a clinical-stage biotechnology firm dedicated to developing novel treatments for conditions with significant unmet medical needs. The company's pipeline features several promising candidates, including SYN-004, which is engineered to break down commonly used intravenous beta-lactam antibiotics in the gastrointestinal tract. This degradation aims to avert microbiome damage, Clostridioides difficile infection (CDI), the overgrowth of harmful organisms, the rise of antimicrobial resistance (AMR), and acute graft-versus-host disease (aGVHD) in patients undergoing allogeneic hematopoietic cell transplants. Another key investigational therapy is SYN-020, an orally adminis...[Read more]
Industry
Biotechnology
IPO Date
2006-12-18
Stock Exchange
AMEX
Ticker
TOVX
According to Theriva Biologics, Inc.’s latest financial reports and current stock price. The company's current ROE is -178.29%. This represents a change of 233.43% compared to the average of -53.47% of the last 4 quarters.
The mean historical ROE of Theriva Biologics, Inc. over the last ten years is -37.44%. The current -178.29% ROE has changed 376.17% with respect to the historical average. Over the past ten years (40 quarters), TOVX's ROE was at its highest in in the September 2017 quarter at 228.11%. The ROE was at its lowest in in the June 2016 quarter at -247.69%.
Average
-37.44%
Median
-76.38%
Minimum
-708.84%
Maximum
1.01%
Discovering the peaks and valleys of Theriva Biologics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 191.07%
Maximum Annual ROE = 1.01%
Minimum Annual Increase = -243.09%
Minimum Annual ROE = -708.84%
| Year | ROE | Change |
|---|---|---|
| 2025 | -164.14% | 22.00% |
| 2024 | -134.54% | 191.07% |
| 2023 | -46.22% | 28.12% |
| 2022 | -36.08% | 65.40% |
| 2021 | -21.81% | -82.56% |
| 2020 | -125.05% | 17.39% |
| 2019 | -106.53% | 134.02% |
| 2018 | -45.52% | -104.49% |
| 2017 | 1.01% | -243.09% |
| 2016 | -708.84% | 160.14% |
The current ROE of Theriva Biologics, Inc. (TOVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-114.97%
5-year avg
-80.56%
10-year avg
-37.44%
Theriva Biologics, Inc.’s ROE is greater than Galmed Pharmaceuticals Ltd. (-57.04%), greater than BioVie Inc. (-101.09%), less than NKGen Biotech, Inc. Common Stock (55.88%), greater than PMGC Holdings Inc. (-116.96%), less than Moolec Science S.A. (376.84%), greater than iSpecimen Inc. (-584.67%), greater than Windtree Therapeutics, Inc. (-1302.82%), greater than BriaCell Therapeutics Corp. Warrant (-147.92%), greater than Chemomab Therapeutics Ltd. (-67.85%), greater than Carisma Therapeutics, Inc. (-28.86%),
| Company | ROE | Market cap |
|---|---|---|
| -57.04% | $3.35M | |
| -101.09% | $12.29M | |
| 55.88% | $7.84M | |
| -116.96% | $2.85M | |
| 376.84% | $5.55M | |
| -584.67% | $381.87K | |
| -1302.82% | $674.18K | |
| -147.92% | $150.51K | |
| -67.85% | $10.16M | |
| -28.86% | $255.25K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theriva Biologics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theriva Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Theriva Biologics, Inc.'s ROE?
How is the ROE calculated for Theriva Biologics, Inc. (TOVX)?
What is the highest ROE for Theriva Biologics, Inc. (TOVX)?
What is the 3-year average ROE for Theriva Biologics, Inc. (TOVX)?
What is the 5-year average ROE for Theriva Biologics, Inc. (TOVX)?
How does the current ROE for Theriva Biologics, Inc. (TOVX) compare to its historical average?